SCHEMBL1584473

SCHEMBL1584473

CC(C)(C)OC(=O)NCCNC(=O)C(C)(C)Oc1ccc(Cl)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
POLB P06746 2/20 0.54
MAPT P10636 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
USP2 O75604 1/20 0.54
HTT P42858 1/20 0.54
LMNA P02545 1/20 0.54
PPARA Q07869 6/20 0.53
TDP1 Q9NUW8 1/20 0.52
PTGS2 P35354 1/20 0.52
CYP1A2 P05177 3/20 0.51
CYP3A4 P08684 3/20 0.51
CYP2D6 P10635 2/20 0.51
CYP2C19 P33261 2/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
CYP2C9 P11712 1/20 0.50
ABCB11 O95342 1/20 0.49
TSHR P16473 1/20 0.49
HTR2A P28223 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1584689 0.94 PPARA (0.56) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL22221443 0.89 PPARA (0.54) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL1584416 0.87 PPARA (0.52) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL1583983 0.86 PPARA (0.51) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL12707617 0.86 PPARA (0.51) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL12707622 0.85 PPARA (0.50) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL1584444 0.85 PPARA (0.50) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL1584133 0.85 PPARA (0.59) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL23903287 0.82 ALDH1A1 (0.57) ALDH1A1POLBMAPTSMN1; SMN2USP2
SCHEMBL1585228 0.82 POLB (0.58) ALDH1A1POLBMAPTSMN1; SMN2USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011044141-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2011-04-14 WO disclosed
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES FABP1, PPARA, FABP4 ALDH1A1 857/4885POLB 3386/4885MAPT 2716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.